AmerisourceBergen   Report issue

For profit Phase 2
Founded: Chesterbrook PA United States (2001)
Status: Left NME R&D (2011)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1980

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ABC HOLDING

Active Ingredients

Marketed Drugs (6)

chlorothiazide (diuril) (1978)

hydrochlorothiazide (esidrix) (1977)

meclizine (antivert) (1977)

phendimetrazine (plegine) (1977)

phentermine (wyamine) (1980)

reserpine (serpasil) (1979)

Drugs in Phase 2 Trials (1)

Key: AmerisourceBergen (0) Acquired (1)

trifolium pratense (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1